Literature DB >> 2491777

Genetic linkage mapping of chromosome 17 markers and neurofibromatosis type I.

J M Vance1, M A Pericak-Vance, L H Yamaoka, M C Speer, G O Rosenwasser, K Small, P C Gaskell, W Y Hung, M J Alberts, C S Haynes.   

Abstract

The von Recklinghausen neurofibromatosis (NF1) gene has been localized to the pericentromeric region of chromosome 17. We have screened six multigenerational families with multiple, tightly linked markers to aid in mapping this region of the chromosome. More than 150 members in six families were typed with probes including HHH202, D17Z1, EW203, EW206, EW207, EW301, pA10-41, D17S37, and D17S36. Two-point lod scores for NF1 versus all markers were calculated. HHH202 demonstrated the tightest linkage to NF1 with theta = .0, z = 3.86 (95% confidence limits [CL] of theta = .0-.13), suggesting that HHH202 be considered as a potential candidate marker for use in carrier detection and prenatal diagnosis. Pairwise marker-to-marker lod scores were used in examining the most likely order of subsets of the markers. Of those tested, the most likely order was (pter)-pA10-41-EW301-D17Z1-HHH202-NF1-E W206-EW207-EW203-(qter). In addition, we have ascertained an NF1 x NF1 half-cousin mating in which there are four affected family members who are potentially homozygous for the disease gene. Two of these four individuals have been sampled and typed for marker loci. When their D17Z1 genotypes are considered, the probability that both these individuals are heterozygous is 85%.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2491777      PMCID: PMC1715473     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  13 in total

1.  Penetrance and variability in neurofibromatosis: a genetic study of 60 families.

Authors:  J C Carey; J M Laub; B D Hall
Journal:  Birth Defects Orig Artic Ser       Date:  1979

2.  Estimation of the recombination fraction in human pedigrees: efficient computation of the likelihood for human linkage studies.

Authors:  J Ott
Journal:  Am J Hum Genet       Date:  1974-09       Impact factor: 11.025

3.  Genetic linkage of von Recklinghausen neurofibromatosis to the nerve growth factor receptor gene.

Authors:  B R Seizinger; G A Rouleau; L J Ozelius; A H Lane; A G Faryniarz; M V Chao; S Huson; B R Korf; D M Parry; M A Pericak-Vance
Journal:  Cell       Date:  1987-06-05       Impact factor: 41.582

4.  A polymorphic DNA marker genetically linked to Huntington's disease.

Authors:  J F Gusella; N S Wexler; P M Conneally; S L Naylor; M A Anderson; R E Tanzi; P C Watkins; K Ottina; M R Wallace; A Y Sakaguchi
Journal:  Nature       Date:  1983 Nov 17-23       Impact factor: 49.962

Review 5.  Von Recklinghausen neurofibromatosis.

Authors:  V M Riccardi
Journal:  N Engl J Med       Date:  1981-12-31       Impact factor: 91.245

6.  A revised map of chromosome 1.

Authors:  S L Sherman; J King; E B Robson; S Yee
Journal:  Ann Hum Genet       Date:  1984-07       Impact factor: 1.670

7.  Huntington disease: estimation of heterozygote status using linked genetic markers.

Authors:  P M Conneally; M R Wallace; J F Gusella; N S Wexler
Journal:  Genet Epidemiol       Date:  1984       Impact factor: 2.135

8.  Gene for von Recklinghausen neurofibromatosis is in the pericentromeric region of chromosome 17.

Authors:  D Barker; E Wright; K Nguyen; L Cannon; P Fain; D Goldgar; D T Bishop; J Carey; B Baty; J Kivlin
Journal:  Science       Date:  1987-05-29       Impact factor: 47.728

9.  Strategies for multilocus linkage analysis in humans.

Authors:  G M Lathrop; J M Lalouel; C Julier; J Ott
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

10.  Cystic fibrosis locus defined by a genetically linked polymorphic DNA marker.

Authors:  L C Tsui; M Buchwald; D Barker; J C Braman; R Knowlton; J W Schumm; H Eiberg; J Mohr; D Kennedy; N Plavsic
Journal:  Science       Date:  1985-11-29       Impact factor: 47.728

View more
  7 in total

1.  The von Recklinghausen neurofibromatosis region on chromosome 17--genetic and physical maps come into focus.

Authors:  F S Collins; B A Ponder; B R Seizinger; C J Epstein
Journal:  Am J Hum Genet       Date:  1989-01       Impact factor: 11.025

2.  Linkage analysis of neurofibromatosis type 1. Study of a homogeneous North Italian population with five DNA markers of chromosome 17.

Authors:  M Clementi; A Murgia; F Anglani; R Tenconi; L Turolla; L Picci; F Zacchello
Journal:  Hum Genet       Date:  1991-05       Impact factor: 4.132

3.  Multipoint linkage analysis in neurofibromatosis type I: an international collaboration.

Authors:  D E Goldgar; P Green; D M Parry; J J Mulvihill
Journal:  Am J Hum Genet       Date:  1989-01       Impact factor: 11.025

4.  A refined genetic map of the region of chromosome 17 surrounding the von Recklinghausen neurofibromatosis (NF1) gene.

Authors:  S R Diehl; M Boehnke; R P Erickson; L M Ploughman; K A Seiler; J L Lieberman; H B Clarke; M A Bruce; E K Schorry; M Pericak-Vance
Journal:  Am J Hum Genet       Date:  1989-01       Impact factor: 11.025

Review 5.  A knowledge network for a dynamic taxonomy of psychiatric disease.

Authors:  Ranga R Krishnan
Journal:  Dialogues Clin Neurosci       Date:  2015-03       Impact factor: 5.986

6.  Heat hyperalgesia and mechanical hypersensitivity induced by calcitonin gene-related peptide in a mouse model of neurofibromatosis.

Authors:  Stephanie White; Blanca Marquez de Prado; Andrew F Russo; Donna L Hammond
Journal:  PLoS One       Date:  2014-09-03       Impact factor: 3.240

7.  Novel pedigree analysis implicates DNA repair and chromatin remodeling in multiple myeloma risk.

Authors:  Rosalie G Waller; Todd M Darlington; Xiaomu Wei; Michael J Madsen; Alun Thomas; Karen Curtin; Hilary Coon; Venkatesh Rajamanickam; Justin Musinsky; David Jayabalan; Djordje Atanackovic; S Vincent Rajkumar; Shaji Kumar; Susan Slager; Mridu Middha; Perrine Galia; Delphine Demangel; Mohamed Salama; Vijai Joseph; James McKay; Kenneth Offit; Robert J Klein; Steven M Lipkin; Charles Dumontet; Celine M Vachon; Nicola J Camp
Journal:  PLoS Genet       Date:  2018-02-01       Impact factor: 5.917

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.